Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (19)

2023

  1. Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530

2022

  1. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

  2. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2020

  1. Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design

    American Heart Journal, Vol. 222, pp. 174-182

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

  2. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study

    Catheterization and Cardiovascular Interventions, Vol. 91, Núm. 3, pp. 435-443

2017

  1. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

    European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134

2016

  1. Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients with In-Stent Restenosis (from the RIBS IV and v Randomized Clinical Trials)

    American Journal of Cardiology, Vol. 117, Núm. 4, pp. 546-554

  2. Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)

    American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584

  3. Tipología y estándares de calidad de las unidades de insuficiencia cardiaca: consenso científico de la Sociedad Española de Cardiología

    Revista Espanola de Cardiologia, Vol. 69, Núm. 10, pp. 940-950

2015

  1. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

    Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33

2014

  1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386

  2. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"

    Circulation

2013

  1. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Circulation, Vol. 128, Núm. 14, pp. 1495-1503

  2. In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011

    Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958

2012

  1. Study design for the effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion (METOCARD-CNIC): A randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction

    American Heart Journal, Vol. 164, Núm. 4

2010

  1. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation

    Circulation, Vol. 122, Núm. 10, pp. 1017-1025

2007

  1. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: Results of a multicenter registry

    Catheterization and Cardiovascular Interventions, Vol. 69, Núm. 3, pp. 372-377

2005

  1. Características y mortalidad del infarto agudo de miocardio tratado con intervencionismo coronario percutáneo primario en España. Resultados del Registro TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos)

    Revista Espanola de Cardiologia, Vol. 58, Núm. 4, pp. 341-350